Dr. Hannah Thompson, Chief Product and People Officer of Cambridge Cancer Genomics (CCG.ai), was today named on BioBeat’s annual 50 Movers and Shakers in BioBusiness report, highlighting the trailblazers and trendsetters shaping the future of the UK life sciences sector.
Nominated for her commitment to collaboration through her work, and her focus on simplifying software for monitoring cancer patients, Hannah joins an illustrious list of leaders shaping the UK life sciences sector. Hannah was awarded for bringing together cancer patients and oncologists for the development of an artificial intelligence platform for treatment monitoring; helping to secure the first industry access to data from Genomics England’s 100,000 Genomes Project; and generating pre-Series A revenue and adoption of the technology by genomic labs and clinics.
Hannah Thompson, Chief Product and People Officer at CCG.ai, says: “I am absolutely thrilled to be on this year’s ‘50 Movers and Shakers in BioBusiness’ report. To be named among such inspirational people is a huge honour and very exciting! The UK life science sector is so vibrant and I feel incredibly humbled to be recognised amongst its successes.”
As well as showcasing the talent and impact of these 50 leaders, the report distils their insights across five themes - science, finance, collaboration, patient impact and infrastructure – providing an invaluable resource for entrepreneurs, researchers and anyone interested in the direction of the industry.
Introducing this year’s report, Melanie Lee, CEO of LifeArc, says: “Everyone working in life sciences shares a great mission: to discover, develop and deliver valuable solutions that improve health and wellbeing for humanity. The 50 Movers and Shakers in BioBusiness 2019 are outstanding examples of leaders delivering on this mission. There is a breadth of innovative, scientific ideas which are igniting biosciences in Britain and each of these women should be celebrated for leading in this thriving sector.”
BioBeat founder Miranda Weston-Smith adds: “It’s a privilege to connect with these incredible leaders, discovering their work and hearing their thoughts on the direction of the industry. Their insights guide our thinking on the opportunities and challenges facing the UK life sciences sector, revealing how to harness the brightest and best ideas to make a difference for patients. These women are the ones to watch!”
The 50 Movers and Shakers report is released in advance of the BioBeat19 summit: Accelerating Cell and Gene Therapy, hosted in partnership with GSK and Stevenage Bioscience Catalyst at GSK Stevenage on Tuesday 19 November 2019.
This year’s summit brings together an international lineup of speakers and panellists drawn from the commercial, academic and public sectors to explore the UK’s advantage and opportunities in this fast-growing field.
The full 50 Movers & Shakers in BioBusiness 2019 report is available to download here
For further information please contact:
Miranda Weston-Smith, BioBeat - Miranda@mws-consulting.co.uk
Belle Taylor, Cambridge Cancer Genomics - email@example.com
About Cambridge Cancer Genomics
Cambridge Cancer Genomics (CCG.ai) is a Y combinator backed startup, building the software to enable data-driven precision oncology. Their precision AI platform, OncOS, enables oncologists to provide more effective, personalised cancer treatment for everyone. CCG.ai’s technology analyses and interprets DNA from a cancer patient, providing genomic insights into individual tumours as they change and grow; gives actionable insights into therapeutic effectiveness; and delivers personalised treatment and trial recommendations. CCG.ai are on a mission to ensure that each patient has the right treatment, at the right time, to beat their cancer.
Find out more at ccg.ai
BioBeat connects entrepreneurs with leaders in biotech, by working to respond to challenges and open opportunities through the inspirational experience of women leaders. Miranda Weston-Smith founded BioBeat to bring fresh energy and insights into biotech for a healthier world.
BioBeat has produced the 50 Movers & Shakers in BioBusiness report every year since 2014, identifying outstanding female leadership talent in UK bioscience. The annual BioBeat summit brings together pioneers in biotech to nurture innovation and forge new partnerships.
Find out more at mws-consulting.co.uk/biobeat/
About BioBeat’s 50 Movers and Shakers in BioBusiness report
The women highlighted in this year’s report have been nominated by the biobusiness community, together with Miranda’s research and insights. The selection was reviewed by a distinguished panel of business leaders, entrepreneurs and pioneering scientists working in the UK life sciences sector.
It has been produced with the support of: